---
title: "Pertuzumab"
slug: "pertuzumab"
date: "2023-10-09"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Stage II-of-Preoperative Chemotherapy for Operable Breast Cancer]]

# Pertuzumab

 (Perjeta)

- Mechanism: Binds to HER2 (binds to a different HER2 epitope than trastuzumab)
- Dosing: 840 mg IV Ã— 1, then 420 mg every 3 wks
- PK/PD: T1/2 âˆ¼18 d
- AEs: Cardiotoxicity, HSR, diarrhea, leukopenia, neutropenia
- DDI: No known pathways of metabolism
